Catalyst
Slingshot members are tracking this event:
Dermira (DERM) Expects Initiation of Phase 3 Trial in H1 2017 Evaluating DRM01 for Acne Vulgaris
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| DERM |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 03, 2017
Occurred Source:
http://investor.dermira.com/phoenix.zhtml?c=253686&p=irol-newsArticle&ID=2233307
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Acne, Drm01
